Europe Solidaire Sans Frontières
, by MALAN Mia
Getting scientists to develop a medicine is a relatively small part of the solution to a pandemic. The more difficult thing is to get the medicine to the people who need it
If you were a South African health journalist during the late 1990s and early 2000s, you were mostly an Aids reporter. (...)
, by Van CUTSEM Gilles
On 5 June 1981 a short report of five cases of pneumocystis pneumonia in young homosexual men in Los Angeles marked the discovery of AIDS, the first pandemic of the 20th century caused by a completely new virus, HIV.
Since then HIV has killed 33 million and infected 76 million people. Of the (...)
, by BEKKER Linda-Gail
World AIDS Day this year finds us still deep amid another pandemic – COVID-19.
The highly infectious novel coronavirus has swept across the world, devastating health systems and laying waste to economies as governments introduced drastic measures to contain the spread. Not since the HIV/AIDS (...)
, by FRIEDMAN Sam
THE MEDIA RARELY discuss AIDS anymore, and when a news report does appear it usually is about a new drug that helps people stay alive longer or even about “the end of AIDS.” Many doctors and biomedical researchers think that findings in the last five years have opened the way to use (...)
, par Fourth International
Since AIDS was first identified among gay men in the USA in 1981, the association of HIV has led to global stigmatization of sex between men, and a repathologizing of homosexuality.
Lesbian/gay activists have sometimes dropped other lesbian/gay political work in face of the urgency of the (...)
, by ROBSON Peter
While there are treatments to slow the progression of AIDS, adding decades to sufferers’ lives, access to them is a case study in the vast gap between rich and poor nations. Few deny that HIV/AIDS is a massive health crisis. What is now clear is that it is also a social one, exacerbated by the (...)
, by TEN KATE Daniel
Thailand’s generic AIDS drugs don’t meet international standards and so questions about their efficacy linger.
On its face, the issue seems black and white: In issuing a compulsory license to import or produce the generic second-line HIV/AIDS drug efavirenz on November 29—two days before (...)
, by Act Up-Paris, EATG, Global Network of People with HIV, Health GAP
The WTO Council for intellectual property is set to meet, tomorrow November 29, for the last time before the WTO Ministerial meeting in Hong Kong. The TRIPS Council will be considering proposals to amend the 1995 TRIPS Agreement in order to permit the exportation of generic medicines produced (...)
Twitter
Facebook